Matthew B. Frankel

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ.

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Micropharma Ltd. formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products. The company was founded by Satya Prakash in 2002 and is headquartered in North Vancouver, Canada.

OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC.

Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA.

Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.

OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.

The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators.

The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40.

RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel.

Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.

MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA.

BioGenCell Ltd. is an Israeli company based at Laniado Hospital in Israel that is dedicated to improving the lives of patients suffering from degenerative microvascular diseases. The company is based in Netanya, Israel. The company aims to extend its reach to address a wider range of vascular and other diseases in the future. BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments since its inception in 2008. The company's groundbreaking tract technology uses a patient's own blood as personalized medicine. BioGenCell's personalized treatments are produced from the patients' own cells, mimicking the body's natural processes. The company was founded by Michael Belkin, Yael Porat, and Eyal Peleg, and Yael Porat has been the CEO since incorporation.

Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel.

TytoCare Ltd. develops handheld devices and telehealth platform. Its products include TytoHome, TytoPro and TytoClinic. The firm specializes in medical devices, digital health, consumer, home monitoring and mobile health. The company was founded by Dedi Gilad and Ofer Tzadik in 2012 and is headquartered in Netanya, Israel.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

SmartZyme Biopharma, Inc. provides platform for protein design and engineering in accordance with industry required specifications. The company was founded by David Baram and Shilo Ben Zeev in 2013 and is headquartered in Ness Ziona, Israel.

Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA.

Impulse Dynamics Ltd. (US) develops implantable device for the treatment of chronic heart failure. The company is headquartered in Mount Laurel, NJ.

Seegnal EHealth Ltd. engages in the creation, marketing and servicing of proprietary technology solution for the electronic health industry. The company was founded by Roni Shiloh in 2012 and is headquartered in Savyon, Israel.

Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA.